CARDIOVASCULAR RISK FACTORS

You have access
Cardiometabolic Effects of Apremilast in Patients With Psoriatic Arthritis: A Prospective Cohort Study
Romy Hansildaar, Eva H. van Geel, Fatih Çoban, Bas Dijkshoorn, Maaike Heslinga, Reinhard Bos, Mies A. Korteweg, Arno W.R. van Kuijk and Michael T. Nurmohamed

The Journal of Rheumatology July 1 2025, 52 (7) 678-686; DOI: https://doi.org/10.3899/jrheum.2024-0791
You have access
Disease Activity Score in 28 Joints Using GGT Permits a Dual Evaluation of Joint Activity and Cardiovascular Risk
Hélène Vergneault, Eloïse Vandebeuque, Veronica Codullo, Yannick Allanore and Jérôme Avouac

The Journal of Rheumatology December 1 2020, 47 (12) 1738-1745; DOI: https://doi.org/10.3899/jrheum.200185
You have access
The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study
Marion Couderc, Bruno Pereira, Anna Molto, Aurélien Tiple, Martin Soubrier and Maxime Dougados

The Journal of Rheumatology June 1 2018, 45 (6) 795-801; DOI: https://doi.org/10.3899/jrheum.170133
You have access
Peripheral Arterial Disease in Systemic Lupus Erythematosus: Prevalence and Risk Factors
Jose Gabriel Erdozain, Irama Villar, Javier Nieto and Guillermo Ruiz-Irastorza

The Journal of Rheumatology February 1 2014, 41 (2) 310-317; DOI: https://doi.org/10.3899/jrheum.130817

Main menu